Increasing Intracellular Bioavailable Copper Selectively Targets Prostate Cancer Cells

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation2001 · 135 citations
2. 2The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson’s disease2012 · 182 citations
3. 3Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner <i>in vitro</i>, in mice and in a patient with metastatic disease2004 · 172 citations
4. 4A Grading Scheme for the Assessment of Proliferative Lesions of the Mouse Prostate in the TRAMP Model2003 · 73 citations
5. 5Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation2009 · 276 citations